Valeant Investigation

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) plummeted more than 12 percent Monday afternoon and hit a new 52-week low of $17.75 following a Bloomberg report that U.S. prosecutors are focusing on the company's ex-CEO and ex-CFO. Bloomberg reported shortly before Monday's market close...